Home › Companies › DIANTHUS THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and DIANTHUS THERAPEUTICS INC.’s Form 8-K, filed May 22, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of May 22, 2025: 4 items on DIANTHUS THERAPEUTICS INC.’s Form 8-K, filed May 22, 2025: 2 approved · 2 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore DIANTHUS THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DIANTHUS THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 22, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Marino Garcia | 23,703,737 | -- | -- | 2,122,220 | 1,996,674 | 92% | Not verified | — |
| Elect Director: Paula Soteropoulos | 22,695,868 | -- | -- | 3,130,089 | 1,996,674 | 88% | Not verified | — |
| 2. Advisory Vote on Executive Compensation | 22,132,031 | 3,684,797 | 9,129 | -- | 1,996,674 | 86% | Approved | — |
| 3. Ratification of Appointment of Independent Registered Public Accounting Firm | 27,812,736 | 1,706 | 8,189 | -- | -- | 99.9% | Approved | — |
Source: DIANTHUS THERAPEUTICS INC., Form 8-K, filed with the SEC on May 22, 2025 — read the filing on EDGAR.
Each item below shows how the 136 asset managers that disclosed a DIANTHUS THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 2 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Description as filed by funds: To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Marino Garcia
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Marino Garcia”): 23,703,737 for, 2,122,220 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 92% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 4,500,416 for, 61,710 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 20,363 | Withhold |
| State Street | 17,492 | 0 | 0 | 20 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 8,063 | Withhold |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 6,432 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 5,324 | Withhold |
| ProShares | 0 | 0 | 0 | 4,757 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 4,375 | Withhold |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 3,559 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,342 | Withhold |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Combines 2 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To elect Class I directors to our Board of Directors, to serve until the 2028 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Paula Soteropoulos
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“Elect Director: Paula Soteropoulos”): 22,695,868 for, 3,130,089 withheld, per its Form 8-K filed May 22, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 3,757,084 for, 805,042 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 557,585 | Withhold |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 110,364 | Withhold |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 50,573 | Withhold |
| Equitable | 9,908 | 0 | 0 | 24,810 | Mixed |
| American Century | 0 | 0 | 0 | 20,363 | Withhold |
| State Street | 17,492 | 0 | 0 | 20 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 8,063 | Withhold |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 6,432 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 5,324 | Withhold |
| ProShares | 0 | 0 | 0 | 4,757 | Withhold |
| ALPS ETF Trust | 0 | 0 | 0 | 4,375 | Withhold |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 3,559 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 0 | 0 | 2,342 | Withhold |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Combines 7 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: To approve, on an advisory basis, the compensation paid to our named executive officers; and
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“2. Advisory Vote on Executive Compensation”): 22,132,031 for, 3,684,797 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation paid to the Company's named executive officers.”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 557,585 | 0 | 0 | Against |
| Vanguard | 0 | 446,119 | 0 | 0 | Against |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 0 | 110,364 | 0 | 0 | Against |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 9,908 | 24,810 | 0 | 0 | Mixed |
| American Century | 0 | 20,363 | 0 | 0 | Against |
| State Street | 17,492 | 20 | 0 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 1 | 8,062 | 0 | Abstain |
| Goldman Sachs | 0 | 7,432 | 0 | 0 | Against |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 0 | 6,432 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 5,324 | 0 | 0 | Against |
| ProShares | 0 | 4,757 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 4,375 | 0 | 0 | Against |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 0 | 3,559 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 0 | 2,342 | 0 | 0 | Against |
Fund voting reports, all 41 managers: 3,352,575 for, 1,201,489 against, 8,062 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 4,053,342 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 2,866,733 | 0 | 0 | 0 | For |
| Fairmount Funds Management LLC | 2,700,691 | 0 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,341,667 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 2,341,613 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 1,744,373 | 0 | 0 | 0 | For |
| Bain Capital Life Sciences Investors, LLC | 1,689,374 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 1,501,624 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 1,027,711 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 863,462 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 769,639 | 0 | 0 | Against |
| Catalio Capital Management, LP | 535,539 | 0 | 0 | 0 | For |
| Point72 | 0 | 481,235 | 0 | 0 | Against |
| Citadel | 441,364 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 381,054 | 0 | 0 | 0 | For |
| GREAT POINT PARTNERS LLC | 275,000 | 0 | 0 | 0 | For |
| Janus Henderson | 0 | 262,148 | 0 | 0 | Against |
| State Street | 254,520 | 1,535 | 0 | 0 | For |
| Candriam S.C.A. | 0 | 248,610 | 0 | 0 | Against |
| BlackRock | 240,033 | 5,282 | 0 | 0 | For |
| Woodline Partners LP | 237,555 | 0 | 0 | 0 | For |
| GV Management Company, L.L.C. | 208,697 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 189,000 | 0 | 0 | Against |
| Charles Schwab | 172,905 | 0 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 134,003 | 0 | 0 | Against |
No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; see all in the interactive database.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE, LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
DIANTHUS THERAPEUTICS INC.’s own tally for this item (“3. Ratification of Appointment of Independent Registered Public Accounting Firm”): 27,812,736 for, 1,706 against — passed, per its Form 8-K filed May 22, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 41 asset managers below reported 4,554,064 for, 8,062 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,982,158 | 0 | 0 | 0 | For |
| AllianceBernstein | 557,585 | 0 | 0 | 0 | For |
| Vanguard | 446,119 | 0 | 0 | 0 | For |
| Charles Schwab | 164,097 | 0 | 0 | 0 | For |
| Principal | 110,364 | 0 | 0 | 0 | For |
| BlackRock | 60,035 | 0 | 0 | 0 | For |
| Northern Trust | 50,573 | 0 | 0 | 0 | For |
| Equitable | 34,718 | 0 | 0 | 0 | For |
| American Century | 20,363 | 0 | 0 | 0 | For |
| State Street | 17,512 | 0 | 0 | 0 | For |
| Lincoln Financial | 17,400 | 0 | 0 | 0 | For |
| TIAA | 13,465 | 0 | 0 | 0 | For |
| Pacific Life | 11,737 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 10,319 | 0 | 0 | 0 | For |
| Brighthouse | 1 | 0 | 8,062 | 0 | Abstain |
| Goldman Sachs | 7,432 | 0 | 0 | 0 | For |
| Global X | 6,523 | 0 | 0 | 0 | For |
| John Hancock | 6,432 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 5,324 | 0 | 0 | 0 | For |
| ProShares | 4,757 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 4,375 | 0 | 0 | 0 | For |
| SEI | 3,900 | 0 | 0 | 0 | For |
| DWS | 3,559 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 2,686 | 0 | 0 | 0 | For |
| Calvert | 2,342 | 0 | 0 | 0 | For |
Showing the 25 largest of 41 asset managers. See all 41 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 32,125,933 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 9.28% |
| 2 | AllianceBernstein | 1.74% |
| 3 | Vanguard | 1.39% |
| 4 | Charles Schwab | 0.51% |
| 5 | Principal | 0.34% |
| 6 | BlackRock | 0.19% |
| 7 | Northern Trust | 0.16% |
| 8 | Equitable | 0.11% |
| 9 | American Century | 0.06% |
| 10 | State Street | 0.05% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 12.62% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.92% |
| 3 | Fairmount Funds Management LLC | 8.41% |
| 4 | Octagon Capital Advisors LP | 7.29% |
| 5 | Deep Track Capital, LP | 7.29% |
| 6 | VR Adviser, LLC | 5.43% |
| 7 | Bain Capital Life Sciences Investors, LLC | 5.26% |
| 8 | TCG Crossover Management, LLC | 4.67% |
| 9 | 5AM Venture Management, LLC | 3.20% |
| 10 | AllianceBernstein | 2.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR (Fidelity) | 13.95% | 13F |
| Sirenia Capital Management LP | 8.71% | 13G |
| RA Capital Management, L.P. | 8.13% | 13G |
| Wellington Management Group LLP | 8.08% | 13G |
| Fairmount Funds Management LLC | 6.66% | 13D |
| Avidity Partners Management LP | 6.55% | 13D |
| BlackRock | 5.03% | 13F |
| TCG Crossover GP II, LLC | 4.67% | 13G |
| Point72 | 4.63% | 13F |
| BCLS Fund III Investments, LP | 4.10% | 13G |
Percentages above are of 32,125,933 shares outstanding, as reported by DIANTHUS THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DIANTHUS THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At DIANTHUS THERAPEUTICS INC.'s shareholder meeting held May 22, 2025, in the 2024-2025 proxy season, 136 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 620 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to our named executive officers; and — DIANTHUS THERAPEUTICS INC.'s filing reports the proposal as approved, with 86% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: DIANTHUS THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 22, 2025.
DIANTHUS THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.